Amicus Therapeutics, Inc.

FOLDNASDAQHealthcare

$14.49

+$0.00(+0.00%)

Market Cap$4.5B

P/E Ratio—

52W High$14.5

52W Low$5.51

Avg Volume4.2M

Open$14.49

Beta0.48

Employees Ownership Insider Trades

Amicus Therapeutics, Inc. (FOLD) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · FOLD · as of Feb 20, 2026

Latest filing snapshot

511

+12+2.40%vs prior year

Amicus Therapeutics, Inc. (FOLD) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

511

Change (1Y)

+12

Growth % (1Y)

+2.40%

Revenue / Employee

$1.24M

Net Income / Employee

$-53.1K

Market Cap

$4.5B

FOLD Employee Count

2007 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-20	2025-12-31	511	+12	+2.40%
2025-02-19	2024-12-31	499	-18	-3.48%
2024-02-28	2023-12-31	517	+33	+6.82%
2023-03-01	2022-12-31	484	-12	-2.42%
2022-02-24	2021-12-31	496	+13	+2.69%
2021-03-01	2020-12-31	483	-101	-17.29%
2020-03-02	2019-12-31	584	+76	+14.96%
2019-02-28	2018-12-31	508	+183	+56.31%
2018-03-01	2017-12-31	325	+62	+23.57%
2017-03-01	2016-12-31	263	+78	+42.16%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ADPT

Adaptive Biotechnologies Corporation

619$2.7B #2

FOLD

Amicus Therapeutics, Inc.YOU

511$4.5B #3

ARQT

Arcutis Biotherapeutics, Inc.

342$2.6B #4

KNSA

Kiniksa Pharmaceuticals, Ltd.

315$3.6B #5

CPRX

Catalyst Pharmaceuticals, Inc.

181$3.8B #6

IDYA

IDEAYA Biosciences, Inc.

131$2.7B #7

CDTX

Cidara Therapeutics, Inc.

38$5.6B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · FOLD peer comparison

About FOLD employees

FOLD Employees · Headcount

Amicus Therapeutics, Inc. (FOLD) employee data is sourced from the annual SEC 10-K filing. As of 2025, Amicus Therapeutics, Inc. had 511 full-time employees globally. Full-time employees only. Global consolidated headcount.

Amicus Therapeutics, Inc. employs 511 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.24M, reflecting the company's operational efficiency.

Amicus Therapeutics, Inc.'s workforce increased by 12 (2.40%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Amicus Therapeutics, Inc.'s revenue per employee of $1.24M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

FOLD Employees · 5 questions

As of the latest SEC 10-K filing (2025), Amicus Therapeutics, Inc. had 511 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Amicus Therapeutics, Inc. employee counthow many employees does Amicus Therapeutics, Inc. haveFOLD total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-20